Stockscreener 앱 받기
26.84
1.51%
0.40
시장 영업 전:
26.00
-0.84
-3.13%
전일 마감가:
$26.44
열려 있는:
$26.59
하루 거래량:
474.23K
Relative Volume:
0.60
시가총액:
$1.64B
수익:
-
순이익/손실:
$-197.68M
주가수익비율:
-7.1383
EPS:
-3.76
순현금흐름:
$-158.88M
1주 성능:
-2.82%
1개월 성능:
+19.93%
6개월 성능:
+213.92%
1년 성능:
+610.05%
1일 변동 폭
$26.19
$27.55
1주일 범위
$25.15
$28.29
52주 변동 폭
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
26.84 | 1.61B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Kodiak Sciences Inc face regulatory challenges2025 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug Retail: Is Kodiak Sciences Inc a turnaround storyJuly 2025 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Assessing Kodiak Sciences (KOD) Valuation After Baker Bros. Buying And Late Stage Retinal Trial Progress - Sahm
Kodiak Sciences (KOD) Price Target Increased by 15.58% to 36.21 - Nasdaq
Can Kodiak Sciences Inc. outperform in the next rallyPortfolio Performance Summary & Daily Stock Trend Watchlist - mfd.ru
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return - Yahoo Finance
Earnings Miss: Is Kodiak Sciences Inc stock a smart retirement pickJuly 2025 Market Mood & Fast Gain Stock Tips - baoquankhu1.vn
Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy - AOL.com
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9%Here's What Happened - MarketBeat
First Week of April 17th Options Trading For Kodiak Sciences (KOD) - Nasdaq
Will Kodiak Sciences Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Risk Managed Investment Signals - mfd.ru
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead - AOL.com
History Review: Is Kodiak Sciences Inc a turnaround story2025 Performance Recap & Growth Focused Entry Reports - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Shares Up 10.9%Should You Buy? - MarketBeat
GSA Capital Partners LLP Sells 76,735 Shares of Kodiak Sciences Inc. $KOD - MarketBeat
Perlroth reports 9.9% Kodiak Sciences (KOD) stake in 13G/A - Stock Titan
Will Kodiak Sciences Inc. benefit from seasonality2025 EndofYear Setup & AI Powered Buy/Sell Recommendations - mfd.ru
Will Kodiak Sciences Inc. benefit from AI trendsQuarterly Investment Review & Low Risk Growth Stock Ideas - mfd.ru
Will Kodiak Sciences Inc. outperform the market in YEAREarnings Recap Summary & Verified Entry Point Signals - mfd.ru
Will Kodiak Sciences Inc. stock outperform tech sector in 2025July 2025 Weekly Recap & AI Enhanced Market Trend Forecasts - mfd.ru
KOD Technical Analysis & Stock Price Forecast - Intellectia AI
KOD PE Ratio & Valuation, Is KOD Overvalued - Intellectia AI
Smart Money: Will Kodiak Sciences Inc benefit from AI trendsJuly 2025 Volume & Technical Pattern Alert System - baoquankhu1.vn
What are the analyst revisions for Kodiak Sciences Inc.Is BOIL stock a good investment in YEARJuly 2025 Technicals & Weekly Market Pulse Alerts - mfd.ru
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Kodiak Sciences stock at $38 By Investing.com - Investing.com South Africa
KOD: HC Wainwright & Co. Reiterates Buy Rating with $38 Target | - GuruFocus
HC Wainwright Reaffirms Buy Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat
Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026Slideshow - Seeking Alpha
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares - Eastern Progress
KOD Stock Up 24% in 3 Months: Here's What You Need to Know - TradingView
Aug PostEarnings: Can Kodiak Sciences Inc lead its sector in growthEarnings Miss & Precise Entry and Exit Recommendations - baoquankhu1.vn
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Kodiak Sciences to present final APEX study results at Angiogenesis meeting - Investing.com Nigeria
Kodiak Sciences to present final APEX study results at Angiogenesis meeting By Investing.com - Investing.com South Africa
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 - marketscreener.com
Kodiak Sciences (KOD) Price Target Increased by 11.69% to 31.33 - Nasdaq
Kodiak Sciences raises capital through completed stock offering - MSN
Kodiak Sciences: A Stellar Move (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences: GLOW2 Readout as Key Catalyst for Tarcocimab Upside and Broader Pipeline Optionality - TipRanks
Aug Catalysts: Is Kodiak Sciences Inc exposed to currency risks2025 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Aug Retail: Will Kodiak Sciences Inc outperform the market in YEAR - baoquankhu1.vn
Kodiak Sciences (NASDAQ:KOD) Trading 6.5% HigherHere's Why - MarketBeat
Can Kodiak Sciences (KOD) Funding And Readouts Reshape Its Retinal Disease Treatment Narrative? - Sahm
FY2025 EPS Estimates for Kodiak Sciences Lifted by Analyst - MarketBeat
Head to Head Review: Structure Therapeutics (NASDAQ:GPCR) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.6%Here's Why - MarketBeat
HC Wainwright Predicts Kodiak Sciences FY2030 Earnings - MarketBeat
Kodiak Sciences Reaches Analyst Target Price - Nasdaq
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):